BridgePoint Medical

BridgePoint Medical is a private company headquartered in Minneapolis, Minnesota, dedicated to developing innovative and proprietary technologies in the field of interventional cardiology for accessing and treating chronic total occlusions. The treatment of chronic total occlusions remains one of the few unresolved challenges in interventional cardiology today. Approximately 30% of all patients undergoing angiography present with chronic total occlusions, leading to a significantly higher referral rate for more invasive bypass surgery. BridgePoint Medical's CrossBoss™ CTO Catheter and Stingray™ CTO Re-Entry System are currently under investigation and may improve physicians' approaches to treating chronic total occlusions. These technologies leverage known interventional techniques and do not require cumbersome and expensive capital equipment.